Introduction and Objective: Diabetes management is particularly challenging for young adults (ages 18-30) living with diabetes (YAWD). To better support this population during this pivotal life stage, four online educational modules were developed that address key aspects of diabetes care.Aim: To evaluate the impact and relevance on aspects of diabetes management of four online topic modules on YAWD and to assess changes in HbA1c and/or time-in-range (TIR) following module completion.Methods: Each topic module incorporates various multimedia modalities. Questionnaires measuring impact (self-reported confidence in self-management) and relevance (participants’ ratings) were administered after each module. Pre- and post-module glycemic (HbA1c, TIR) and diabetes distress (DD) data were collected. A final questionnaire and qualitative interview were conducted after completion of all modules.Results: Fifty-one participants enrolled, with 49 continuing past enrollment. Baseline characteristics: 53% male, 63.3% white, average age 24.1 years, A1c 7.1%. Most participants used a CGM (95.9%) with average TIR 66.1% (SD 19.8%). Of those with T1D (89.8%), 84.1% used an insulin pump. Forty participants completed Module 1 on “Mental Health & Wellbeing” with most finding it relevant. They reported increased confidence in self-care and distinguishing between burnout and DD, though they lacked confidence in seeking mental health services. Thirty-nine participants completed Module 2 on “Sex & Diabetes” with most finding it relevant and reporting greater confidence in managing diabetes-related challenges associated with sex. Data for Module 3 and 4 is forthcoming.Conclusion: Our findings demonstrate that an online educational resource hub for YAWD was relevant and impactful in enhancing their understanding and management of key issues. It also proved to be a feasible way to deliver accessible learning. Future research should focus on expanding to a more diverse population, with an emphasis on topics that are pertinent to YA with T2D.
M. Roche: None. A. Rieger: None. S. Kim: Consultant; Signos.
Novo Nordisk
Source link
Leave a Reply